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ABSTRACT
Tumor necrosis factor (TNF) is a pro-inflammatory
cytokine that plays an important role in a variety of
infectious and autoimmune disorders. Its transcrip-
tion is regulated in a stimulus- and cell-type-specific
manner via the recruitment of distinct DNA/activator
complexes forming secondary structures or enhan-
ceosomes. NFATp, a member of the nuclear factor
of activated T cells (NFAT) family of transcription fac-
tors,playsacriticalroleinTNFgeneregulationunder
a variety of conditions. In this study, we show that
NFAT5, the most recently described NFAT family
member, binds to the TNF promoter in a manner dis-
tinct from other NFAT proteins and is a key mediator
in the activation of TNF gene transcription during
hypertonic stress alone.
INTRODUCTION
Regulation of the mammalian immune system involves com-
plex mechanisms of transcriptional control. One model gene
system in which cell-type- and inducer-speciﬁc transcriptional
programshave beenstudiedisthehumantumornecrosisfactor
(TNF)gene. Invitroandinvivostudieshave demonstrated that
the mechanisms of transcriptional activation and enhanceo-
some formation involved in TNF gene expression are inducer-
and cell-type-speciﬁc in T cells stimulated through the T-cell
receptor (TCR) or infected with virus (1–4), in monocytic
cells stimulated with lipopolysaccharide or Mycobacterium
tuberculosis (5,6), and in ﬁbroblasts stimulated with recom-
binant TNF (7). Members of the nuclear factor of activated
T cells (NFAT), Sp and Ets families of transcription factors
are recruited to promoter binding sites that are capable of
binding multiple factors. The stimulus, cell type and the
subsequent nuclear concentrations of transcriptional activators
(1–4) induce a unique pattern of activator recruitment to the
promoter.
TNF, a potent pro-inﬂammatory cytokine, plays a critical
role in the immune response that leads to effective clearance
of a variety of pathogens or to immunopathology and auto-
immune disease (8). The transcription factor NFATp (also
called NFAT1 or NFATc2) is a key factor involved in TNF
gene regulation in T and B cells activated via their antigen
receptors, calcium ﬂux or virus (1,3,5,9,10). NFATp (11) is
a member of a family of proteins that has ﬁve members
including NFATc (also called NFAT2 or NFATc1) (12),
NFAT3 (also called NFATc4), NFAT4 (also called NFATx
or NFATc3) (13) and NFAT5 (14) [also called TonEBP (15),
NFATL1 (16), OREBP (17) or NFATz (18)].
NFAT5 is distinct from the other four NFAT family mem-
bers in that (i) it is not regulated by intracellular calcium
levels, (ii) its activity cannot be blocked by calcineurin inhib-
itors, such as Cyclosporine A (CsA) and (iii) it has been
implicated in the production of genes required for the cellular
response to hypertonic stress (14–18). Furthermore, its crystal
structure has revealed that, in contrast to NFATp, NFAT5
binds DNA as an obligate homodimer, similar to NF-kB (19).
Although there is considerable variation in the literature
about the effects of hypertonic stress on cytokine production
(20–22), hypertonic stress alone has been shown to activate
cytokine production, including TNF in macrophage and B
lymphocyte cell lines (23). In Jurkat T cells stimulated with
phorbolester (PMA)and hypertonic saline, TNFmRNAlevels
were increased. Using chromatin immunoprecipitation (ChIP)
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doi:10.1093/nar/gki701binding assays, NFAT5 was shown to be recruited to the
TNF promoter, suggesting that NFAT5 plays a role in TNF
gene regulation in PMA-activated T cells under hypertonic
conditions (24). However, PMA alone activates TNF gene
transcription in Jurkat cells (25). Thus, the role of NFAT5
in TNF induction by hypertonicity alone remains unclear.
Here, we show that NFAT5 binds to the TNF promoter in a
pattern distinct from that of other NFAT family members and
is a key member of the enhancer complex that is recruited to
the TNF promoter under hypertonic conditions.
MATERIALS AND METHODS
Plasmids
The  200 TNF-Luc reporter and isogenic TNF-Luc mutant
constructs were made as described previously (3). The small
hairpin (sh)RNA-expressing constructs were made by cloning
the ﬁrst 315 bp of the murine U6 promoter up to the base
before the G marking the transcriptional start site. The pro-
moter was ampliﬁed from mouse genomic DNA by PCR using
the following primers (with restriction sites on the ends).
Sense: –gcagaattcGATCCGACGCCGCCATCTCT–; anti-
sense: –acaggtaccAAACAAGGCTTTTCTCCAAGGGATA–.
The fragment was cloned between EcoRI and BamHI in
pBluescript (Stratagene). This construct was used as a tem-
plate for PCR of a U6-shRNA construct whose hairpin tar-
geted exon 8 of the NFAT5 gene. A U6-shRNA construct with
a scrambled hairpin was also designed. These PCRs used
a common primer for the 50 end. Sense: –gcagaattcGATCC-
GACGCCGCCATCTCT–. The antisense primers for the
30 ends were as follows: gcagctagcCTCGAGAAAAAAGC-
AATGTCAGAGTAGAGCCCTACACAAAGGCTCTACT-
CTGACATTGCAAACAAGGCTTTTCTCCAAGGGATA–
(shRNA targeting NFAT5 exon 8); gcagctagcCTCGAGAA-
AAAAGAACGTTCGATAATGGATCCTACACAAAGAT-
CCATTATCGAACGTTCAAACAAGGCTTTTCTCCAAG-
GGATA– (scrambled non-silencing shRNA).
The NFAT5-dominant negative (N5-DN) expression plas-
mid was generated by cloning the NFAT5 DNA binding
domain (DBD) into pcDNA3 vector (Invitrogen). The DBD
fragment was ampliﬁed from the pEGFP-N1 vector (Clontech)
containing full-length NFAT5 (24) by PCR using primers with
restriction enzymes EcoRI and XbaI on the ends and ligated
into pcDNA3 vector.
Cell culture and transfection
The murine ﬁbroblast cell line L929 was grown at 37 C,
5% CO2, in DMEM supplemented with 10% fetal bovine
serum (FBS) and 2 mM glutamine. The cells were lightly
trypsinized with 0.05% trypsin in HBSS and EDTA and sub-
cultured as necessary. The T-cell hybridoma 68–41 cell line
was grown at 37 C, 5% CO2, in RPMI-1640 supplemented
with 10% FBS and 2 mM glutamine. Transfections with the
U6-shRNA constructs were performed using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instruc-
tions. All other transfections were performed using
DEAE-dextran as previously described (5). Stimulation was
performed with rafﬁnose (Sigma) as described in the Results
section. Small molecule inhibitor SB203580 was diluted in
dimethyl sulfoxide. It was purchased from Calbiochem. Luci-
ferase assays were carried out according to the manufacturer’s
instructions (Dual Luciferase Reporter Assay System, Pro-
mega) with a Dynex luminometer, using Renilla luciferase
(pRL-TK) as a control for transfection efﬁciency.
RNase protection assay
L929 cells were left unstimulated or stimulated with 200 mM
rafﬁnose for 18 h. Total RNA was puriﬁed using TRIzol
Reagent (GibcoBRL). RNA was hybridized overnight to
[a-
32P]UTP-labeled antisense RNA probes for TNF and
L-32, which had been synthesized in vitro from separate
templates according to standard techniques (9,26,27). After
hybridization, the samples were digested with RNase A to
remove single-stranded ends of hybridized RNA. Proteinase K
was added to stop the digestion reaction, and double-stranded
RNA was puriﬁed by phenol/chloroform extraction followed
by ethanol precipitation. Protected RNA pieces were resolved
on an 8% denaturing polyacrylamide gel and exposed over-
night on ﬁlm.
Western blot analysis
Whole cell extracts were collected with lysis buffer containing
150 mM NaCl, 50 mM Tris–HCl, pH 7.5, 1% Triton, 10%
glycerol and 1 tablet of Complete EDTA-free Protease Inhib-
itor Cocktail (Roche) per 25 ml of buffer. Extracts were stored
at  70 C until ready for use. Extracts were boiled for 5 min in
1· Laemmli sample buffer with 5% v/v 2-mercaptoethanol.
Extracts were run at 100 V on 5% Tris–HCl polyacrylamide
10-well pre-cast gels with a 4% stacking gel (BioRad) with
a Kaleidoscope molecular weight marker. The gel was trans-
ferred to nitrocellulose Trans-Blot Transfer Membrane
(BioRad) at 40 V for 1.5 h in a tank transfer apparatus. The
blot was then blocked for 1 h at 37 C in a solution of 4% BSA
(Sigma) and 0.1% Tween-20 (BioRad) in Tris-buffered saline
with 50 mM Tris and 150 mM NaCl at pH 7.6 (BSA/TBST).
Primary incubation was carried out with 1:200 rabbit-anti-
NFAT5 antibody (Santa Cruz, sc-13035) and 1:500 goat-anti-
Lamin B1 antibody (Santa Cruz, sc-6217) in BSA/TBST for
2 h at room temperature. The blot was washed 3 · 5 min in
TBST and incubated in 1:6000 donkey-anti-goat-HRP (Santa
Cruz) or goat-anti-rabbit-HRP (BioRad) as appropriate for 1 h.
The blot was again washed 3 · 5 min in TBST and developed
with SuperSignal West Pico Chemiluminescent Reagent
(Pierce). Anti-NFATp antibody was generated in the laborat-
ory of Anjana Rao as described previously (11).
DNase I footprinting and electrophoretic
mobility shift assay (EMSA)
DNase I footprinting of the human TNF promoter was carried
out with recombinant DBD of NFAT5 (24), as described pre-
viously(3).Brieﬂy,the 200toþ87fragmentofthewild-type
TNF promoter was end-labeled with [g-
32P]ATP on one end
using T4 polynucleotide kinase and incubated with increasing
amounts of recombinant proteins as labeled in Figure 2. After
30 min of incubation, the samples were digested with 0.3 U
of DNase I for exactly 1 min, resolved on an 8% denaturing
polyacrylamide gel and exposed overnight on ﬁlm. EMSA
was performed, as described previously (28), using oligo-
nucleotides end-labeled with [g-
32P]ATP and DBD5 and
DBD5-GST recombinant proteins or nuclear extracts from
L929 cells left untreated or treated with 200 mM rafﬁnose for
3846 Nucleic Acids Research, 2005, Vol. 33, No. 1218 h. In supershift assay, the appropriate antibodies (Santa
Cruz) were pre-incubated with nuclear extracts for 30 min
before adding the labeled probe. The sequence of the oligos
used is shown in Figure 3. Recombinant proteins were a
kind gift from Tim Hoey, Dimitris Thanos and Anjana Rao.
Escherichia coli expression vectors for each protein were con-
structed and proteins were expressed using T7 polymerase
expression system in the strain BL21 (Invitrogen) and puriﬁed
by DNA afﬁnity chromatography as described in details (13).
The sizes of the different proteins are as follows: NFATp, 353
aminoacids[theresidueshomologousto185–537accordingto
(11)]; NFATc, 309 amino acids [residues 408–716 according
to (12)]; NFAT3, 345 amino acids (residues 400–744)
and NFAT4, 316 amino acids (residues 393–708) according
to (13).
RESULTS
Induction of TNF mRNA and NFAT5 protein
in L929 cells under hypertonic stress
We sought ﬁrst to establish that hypertonic stress alone is
sufﬁcient to activate TNF gene transcription and to validate
L929 murine ﬁbroblast cells as a model system to probe the
roleofNFAT5inTNFtranscription. Weexposed L929cellsto
200 mM rafﬁnose, a large membrane-impermeable sugar
causing intracellular hypertonic stress (29) for 18 h, harvested
RNA and performed an RNase protection assay. As shown in
Figure 1A, endogenous TNF mRNA levels as measured by
RNase protection assay were signiﬁcantly increased by rafﬁn-
ose treatment of L929 cells at 18 h, and we detected this
increase at 3 h post stimulation (data not shown). We also
examined NFAT5 protein levels in stimulated cells by western
blot analysis. Hypertonic stress induced aseveral-foldincrease
in NFAT5 protein levels compared with untreated cells
(Figure 1B). Lamin B1, a nuclear structural protein, was used
as a loading control. As shown in Figure 1C, L929 cells do not
express NFATp, whereas the T cell line 68–41 that we used as
a positive control does express both NFATp and NFAT5 pro-
teins constitutively. The absence of NFATp thus simpliﬁes
the analysis of the role of NFAT5 in hypertonic induction
of TNF gene expression since high levels of NFATp could
potentially interfere with NFAT5 binding to shared sites
within the promoter.
To begin to determine the TNF promoter sequences that
were required for hypertonic induction of TNF, we next trans-
fected two human TNF promoter reporter genes with either
 982 or 200 ntrelative tothe transcription start sitelinkedto
luciferase reporter genes. Transfection of these constructs into
L929 cells that were then treated with rafﬁnose demonstrated
that  200 nt was sufﬁcient for maximal induction of TNF by
hypertonicstress (Figure1D).These resultsare consistent with
these sequences being sufﬁcient for TNF induction using a
variety of stimuli and cell types (1,3,5–7,9,30). We note that
endogenous levels of TNFmRNAhave correlated closely with
the activity of the TNF luciferase reporter in all cell lines
tested to date (Goldfeld lab, unpublished data) (Figure 1).
NFAT5 and NFATp bind the TNF promoter distinctly
The NFAT5 consensus sequence is 50-TGGAAANYNY-30
(14,19). Visual inspection of the TNF promoter reveals
putative NFAT5 consensus binding sequences in both the
 76 and k3-NFAT binding regions, which are two of the
six TNF promoter sites previously shown to bind NFATp.
To determine if and where NFAT5 binds to TNF promoter
sequences, we performed DNase I in vitro footprinting.
A radiolabeled fragment of the human TNF promoter spann-
ing the region from  200 to þ87 nt was incubated with
Figure 1. Hypertonicity induces TNF transcription and NFAT5 expression.
(A) Induction of TNF mRNA by hypertonic stress. L929 cells were cultured in
medium supplemented with 200 mM raffinose for 18 h. RNA was harvested
and submitted to RNase protection assay. (B) Hypertonic stress up-regulates
NFAT5 expression. L929 cells were cultured to  95% confluence in a 6-well
plate and stimulated with complete medium or medium supplemented with
200mMraffinosefor18h,asindicated.Wholecellextractswerecollectedand
submitted to western blot analysis. Results are representative of four
independent experiments. (C) L929 cells do not express NFATp. Whole cell
extract (30 mg) from 68 to 41 cells were submitted to western blot analysis as
a positive control for NFATp expression. L929 cells were stimulated with
hypertonic stress as above. Results are representative of two independent
experiments. Lamin B1 was used as a loading control. (D) Induction of
TNF luciferase activity by hypertonic stress in L929 fibroblasts. A total of
2 · 10
6 L929 cells were transfected with 1 mg  200 TNF-Luc or  982
TNF-Luc and 0.4 mg pTK-RL control vectors by DEAE-dextran. Cells were
stimulated with complete medium supplemented with 200 mM raffinose 24 h
after transfection. Cells were harvested 18 h after stimulation and luciferase
activities were assayed. Results are from four independent experiments. Error
bars are the standard deviation.
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protein and treated with DNase I. This analysis demonstrated
that NFAT5 bound to the k3 site and to the abutting  76
NFAT site, but did not bind to the four other TNF NFAT
binding sites ( 55,  117,  149 and  180), motifs that
bind to NFATp, (2,3,31) (Figure 2, lanes 1–6). The pattern
of binding of NFAT5 is distinct from that of NFATp at all
concentrations of both factors. Using increasing amounts of
recombinanthumanDBD5proteinfusedtoGST(DBD5-GST)
in footprinting analysis gave us identical results with DBD5
protein alone, suggesting that the presence of GST did not
affect DBD5 binding to the TNF promoter (Figure 2) (data
not shown).
RecombinantNFAT5bindsdistinctlytoTNFNFATsites
as compared with NFATp, c, 3 and 4 in vitro
Consistent with the footprinting results presented above using
recombinant NFATp and other footprinting studies using
recombinant NFATc, NFAT3 and NFAT4 (data not shown),
equal amounts of recombinant protein in every case resulted
in stronger binding of these four proteins to the  76 NFAT
site as compared with the k3 site in an EMSA (Figure 3A).
To further compare the binding of NFAT5 with other NFAT
family members, we performed EMSAs with fragments of
the human TNF promoter containing either the  76 NFAT
site, the k3 site (k3L) or both the  76 NFAT site and the
k3 site (k3LL) with NFAT5 (DBD5 or/and a DBD5-GST
fusion protein). Since the sizes of these proteins can be
differentiated on the gel, we were able to demonstrate that
both the DBD5 and DBD5-GST bound the probe containing
both the  76 NFAT site and k3-NFAT sites alone. Moreover,
the proteins bound to the probe containing both sites more
strongly than to either site alone (Figure 3B), consistent with
the DNase I footprinting results demonstrating the occupation
of both sites at the same concentration of NFAT5 (Figure 2).
We note that higher molecular weight complexes are visible
when DBD5-GST is used in EMSA (Figure 3B, lanes 13–16
and lanes 20–26), consistent with the ability of GST to oli-
gomerize.
To further investigate the speciﬁcity of NFAT5 binding to
the k3 and  76 NFAT sites but not to other sites in the TNF
promoter, we performed an EMSA with all ﬁve recombinant
NFAT proteins and a probe spanning the  180 NFAT
sequence in addition to the k3L and k3LL probes. As shown
in Figure 3C, NFATp, c, 3 and 4 all bind similarly to all three
probes. In contrast, NFAT5 does not bind to the  180 NFAT
site. These data further support our hypothesis that NFAT5 has
a unique pattern of binding to the TNF promoter that is distinct
from the other NFAT family members.
NFAT5 is recruited to the k3-NFAT binding site
in osmotically stressed L929 cells
We next performed an EMSA using the strongest NFAT5
binding probe (k3LL) and nuclear extracts from osmotically
stressed L929 cells to demonstrate that NFAT5 indeed can
speciﬁcally bind this site using physiologically stimulated
L929 cells. As shown in Figure 3D, rafﬁnose stimulation of
L929 cells results in the binding of two additional complexes
that form on k3LL probe as compared with what we observed
using nuclear extracts from unstimulated L929 cells (compare
lanes 1 and 2). Furthermore, anti-NFAT5 antibodies inhibit
the formation of the two inducible complexes and a constitu-
tivecomplex(Figure3D,lane3)whereasantibodies toNFATc
and isotype control do not (lanes 6 and 7), demonstrating that
these three complexes contain NFAT5. Moreover, the addition
of antibodies against ATF-2 and c-jun also inhibits the forma-
tion of the same two inducible complexes that contain NFAT5
in rafﬁnose-stimulated L292 nuclear extracts consistent with
the two complexes being formed by NFAT5 together with
ATF-2/c-jun dimer bound to the CRE sequence included in
the k3LL probe (Figure 3D, compare lanes 3–5).
Figure 2. NFAT5 binds to the proximal TNF promoter in a pattern distinct
from NFATp. DNase I footprinting assay of the TNF promoter with NFAT5.
The DBA of recombinant human NFAT5 (DBD5) binds to two sites on the
proximal TNF promoter between  120 and þ87 nt relativeto the transcription
start site. Of the two sites, the  76 NFAT binding site binds at lower protein
concentrations than the k3 site. Increasing concentrations of DBD5 (25 ng,
125ng,500ngand2.5mg)arerepresentedbythewedgeoverlanes3–6.Lighter
bands indicate regions of reduced cleavage by DNase I due to protein binding.
Several known transcription factor binding sites and their locations are indi-
catedtotherightofthegel.RecombinantNFATpbindssixsitesintheproximal
promoter region (see lanes 9–12).
3848 Nucleic Acids Research, 2005, Vol. 33, No. 12Figure 3. NFAT family members bind portions of the TNF promoter with different affinities. (A) EMSA using recombinant NFATp, NFATc, NFAT3 and NFAT4
withportionsofthe TNFpromoter.Threeprobes( 76,k3Landk3LL) wereend-labeled with
32Pandincubatedwithrecombinant protein,asindicated.Freeprobe
markedatthebottomofthegelindicatesequalloading.(B)EMSAusingrecombinantDBD5orDBD5-GSTandprobeswithportionsoftheTNFpromoter.Adiagram
of the proximal human TNF promoter with probes for EMSA is just below.Known binding elements are boxed. Putative NFAT5 binding sites, based on the known
consensussequence, are bracketed. (C) EMSA using recombinant NFATp,NFATc, NFAT3,NFAT4 and NFAT5with portionsof the TNF promoter. Three probes
(k3L, k3LL and  180) were end-labeled with
32P and incubated with recombinant protein, as indicated. Free probe marked at the bottom of the gel indicates equal
loading. (D) EMSA using raffinose-stimulated L929 nuclear extracts and the k3LL probe. Nuclear extracts were prepared from L929 cells unstimulated ( )o r
stimulated (þ) with raffinose (200 mM) for 18 h. An oligonucleotide probe containing the  76 NFAT, k3-NFAT and the CRE binding sites (k3LL) was used and
the binding assay was performed in the presence or absence of antibodies to NFAT5, NFATc, ATF-2, c-jun or isotype control (normal rabbit serum) as indicated in
the figure. The complexes containing NFAT5 or ATF-2 alone are indicated by the gray arrows, and the composite NFAT5/ATF-2/c-jun complexes are indicated
by the black arrows in the figure.
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of recombinant NFAT5 and TNF transcriptional
induction by hypertonic stress
To establish that NFAT5 can bind to each site individually, we
next performed a quantitative DNase I footprinting analysis
withincreasingamounts of DBD5-GST. As shown in Figure 4,
mutation of the k3-NFAT site (30Mo r5 0M) abrogates NFAT5
binding to the k3 site but does not abolish binding to the  76
site (Figure 4A, compare lanes 4–6 with 10–12 and 16–18).
Conversely, mutation of the  76 site does not abolish binding
of NFAT5 to the k3-NFAT site, but abrogates binding of
NFAT5 to the  76 site. We note that the k3-NFAT site
appears darker at the highest levels of DBD5-GST than the
corresponding bands in the WT control only because the  76
mutant gel has a darker exposure overall (Figure 4A, compare
lanes 4–6 with 22–24). In contrast, using a template with a
mutation in the  84-Ets site that is located between the k3 and
 76 NFAT sites, binding of NFAT5 is unaffected (Figure 4A,
lanes 27–30).
To correlate the above binding studies with promoter ele-
ments required for the induction of the TNF gene by hyper-
tonic stress, we next transfected L929 cells with the wild-type
(WT)  200 human TNF-Luc reporter gene or isogenic con-
structs bearing mutations in the k3-NFAT (50M and 30M),  76
NFAT ( 76M), CRE (C1M) and  84-Ets ( 84M) sites (as
shown at the bottom of Figure 4) and stimulated them with
rafﬁnose (Figure 4B). Mutation of the k3o r 76 NFAT sites
signiﬁcantly inhibited induction of the reporter genes by
hypertonic stress, whereas the  84 mutation had no effect
(Figure 4B). We also note that hypertonic induction of TNF
in L929 cells is not sensitive to CsA (data not shown). Thus,
the inhibition of rafﬁnose-stimulated TNF gene expression
by the  76 and k3 site mutations is consistent with their
interference with NFAT5 binding to the  76 and k3 sites
and demonstrates the importance of both of these sites in
the regulation of TNF by hypertonic stress.
The fact that the CRE mutant, which disrupts binding of
ATF-2/c-jun (28), also had a signiﬁcant impact upon rafﬁnose
induction of TNF indicates that ATF-2/c-jun is also involved
in the enhancer complex together with NFAT5. To formally
prove that both ATF-2/c-jun and NFAT5 proteins could
simultaneously bind to the TNF promoter, given the proximity
of the sites, we next performed a quantitative DNase I foot-
printing analysis with ATF-2/c-jun and increasing amounts of
NFAT5. As shown in Figure 4C, ATF-2/c-jun binding to the
CRE is not blocked by NFAT5 at increasing concentrations.
Thus,theCRE/k3/ 76sitesformacompositebindingelement
for ATF-2/c-jun/NFAT5 required for the regulation of TNF
by hypertonic stress.
Blocking NFAT5 with a construct expressing an shRNA
or a dominant negative NFAT5 protein inhibits TNF
reporter activity in response to hypertonic stress
TodemonstratethatNFAT5isacriticalactivatorinhypertonic
induction of the TNF gene, we next employed two approaches:
knockdown of NFAT5 mRNA and co-transfection of a dom-
inant negative form of NFAT5 (24). Although NFAT5 has
been successfully knocked down using synthetic small inter-
fering (si)RNA oligonucleotides (32), this approach was
not successful with NFAT5 in L929 cells (data not shown).
We made shRNA-expressing construct targeting exon 8 of the
murine NFAT5 gene (U6-N5 ex8) under the control of the
murine U6 small nuclear (sn)RNA promoter (Figure 5A). Fur-
thermore, a construct expressing a scrambled shRNA was also
made to serve as a negative control (U6-N). See Figure 5A and
B for diagrams of the transcribed DNA region and shRNAs
from these two constructs. The constructs were co-transfected
into L929 cells with the  200 TNF-Luc vector and the cells
were stimulated with 200 mM rafﬁnose 36 h after transfection
and harvested 18 h after stimulation. As shown in Figure 5C,
there was a statistically signiﬁcant inhibition of TNF reporter
activity in response to hypertonicity in the cells transfected
with U6-N5 ex8 vector as compared with the scrambled con-
trol vector, U6-N. As a control, we performed a western blot
analysis of extracts from cells transfected with the U6-N5 ex8
or U6-N vector and stimulated with hypertonic stress. We
observed a  50% knockdown of NFAT5 protein levels in
cells transfected with U6-N5 ex8 compared with NFAT5 in
cells transfected with the control U6-N vector (Figure 5D).
To further establish a role for NFAT5 in TNF transcription
during hyptertonic stress, increasing amounts of a dominant
negative version of NFAT5 (NFAT5-DN) were transiently
transfected together with the TNF-Luc reporter gene into
L929 cells before hypertonic stimulation. NFAT5-DN sup-
pressed TNF production during hypertonic stress in a dose-
dependent manner (Figure 5E). When the highest concentra-
tion of NFAT5-DN was transfected (6 mg) into L929 cells,
TNF-Luc activity was reduced by  75% as compared with
co-transfection of the same amount of the pcDNA3 vector
alone. Even at half this concentration of NFAT5-DN (3 mg)
the repression of TNF compared with the pcDNA3 control
(6 mg) was highly signiﬁcant (P ¼ 0.01) (Figure 5E). Taken
together with the NFAT5 knockdown experiments, these
studies demonstrate that NFAT5 is a critical activator in
TNF induction by hypertonic stress.
DISCUSSION
TNF gene transcription is controlled by enhanceosome
formation in a stimulus- and cell-type-speciﬁc manner (3–6).
Previous work has shown that NFAT family members play a
critical role in TNF gene expression in T cells stimulated by
TCR ligands, ionophore, virus and superantigen (2,3). This
work broadens the role that NFAT family members play in
TNF transcription by showing that NFAT5 activates TNF
transcription in response to hypertonic stress alone and that
NFAT5 binds to the TNF promoter in a pattern distinct from
other NFAT family members. Thus, a single family of tran-
scription factors achieves speciﬁcity in TNF gene activation
via the diversity of binding patterns of its members in response
to various activation stimuli.
NFAT5 is the only member of the NFAT family to bind the
 76 NFAT and the k3 site, but not to other NFAT sites in
the TNF promoter. We note that the  76 site contains a better
match for the core of the consensus sequence (GGAAA) (see
Figure 3) than does the k3. However, the afﬁnity of NFAT5
for a site may be strengthened when the second half of the site
is similar to the core consensus sequence (19). This observa-
tion may explain as to why NFAT5 binds to the k3-NFAT site
despite the lack of a perfect core consensus sequence.
Nevertheless, the precise reasons, why NFAT5 has high
3850 Nucleic Acids Research, 2005, Vol. 33, No. 12Figure4.Mutationsinthe 76NFATandk3site,butnotinthe 84-Etssite,decreasebindingofrecombinantNFAT5andhypertonicinductionofTNF.(A)DNaseI
footprintingassayofmutatedTNFpromoterwithNFAT5(DBD5-GST).The30Mand50Msitesareinthek3elementandthe 76mutationisinthe 76NFATsite.
The  84 mutationis betweenthese two sites. For a diagram,see the bottom ofthe figure.(B) Relativeactivity ofTNF luciferase constructscontaining mutations in
known binding sites of transcriptional activators. A total of 5 · 10
6 L929 cells were transfected with 1 mg  200 TNF-Luc and 0.2 mg pTK-RL control vectors by
DEAE-dextran.Cellswerestimulatedwithcompletemediumsupplementedwith200mMraffinose24haftertransfection.Cellswereharvested18hafterstimulation
and Photinus luciferase and Renilla activities were assayed. (C) DNase I footprinting assay of competitive binding of NFAT5 and ATF-2/c-jun. The binding of
ANF-2/c-jun to the CRE element was not blocked by increasing amounts of DBD5-GST (see lanes 13–17).
Nucleic Acids Research, 2005, Vol. 33, No. 12 3851afﬁnity for  76 and k3 but not to other NFAT sites in the
proximal promoter, remain to be elucidated.
ATF-2 is a known downstream target of p38 MAP kinase,
which is activated in mammalian cells in response to hyper-
tonic stress (33). We note that treatment with SB203580,
a speciﬁc inhibitor of p38 MAP kinase, reduces the hypertonic
induction of TNF-Luc activity in L929 cells (data not shown).
Inhibition of p38 hasalsobeen shown to block NFAT5 activity
(34). ATF-2/c-jun/NFATp binds to the CRE/k3 composite site
to form the core of the enhanceosome in T cells activated
by TCR ligands or viruses. Our data here suggest that during
hypertonic stress, a new composite element comprising
two NFAT5 dimers binding to  76 and k3-NFAT and
ATF-2/c-jun at the CRE is formed. These data are consistent
with the recruitment of a distinct enhanceosome to the TNF
promoter under hypertonic conditions. TNF was ﬁrst descri-
bed as a target of NFAT5 on the basis of a ChIP assay that
showedthatNFAT5isrecruited tothe TNFpromoterinTcells
after stimulation with hypertonic stress and PMA (24). Our
studygives further evidence that hypertonic stress alone, in the
Figure 5. A vector expressing a shRNA targeting NFAT5 and a dominant negative NFAT5 down-regulate hypertonic induction of TNF luciferase activity.
(A)DiagramoftheshRNA-expressingconstruct.ThemurineU6smallnuclearRNA(snRNA)promoterwasclonedintopBluescriptfollowedbyasequencecoding
fortheshRNAtargetingmurineNFAT5.SeeMaterialsandMethodsfordetails.(B)DiagramoftheshRNAsexpressedfromthescrambledsequence(U6-N)andthe
sequence targeting exon 8 of murine NFAT5 (U6-N5 ex8). (C and D) A vector expressing an shRNA against NFAT5 depresses hypertonic induction of TNF-Luc
activityinL929cellsandlowersNFAT5levels.Atotalof3 · 10
5cellswereplatedin6-wellsplates( 95%confluent)andweretransfectedthenextdaywith0.7mg
TNF-Luc,0.3mgofTK-RLand1mgofeithertheU6-NortheU6-N5ex8vector.Thecellswerestimulatedasindicated36hlaterwithcompletemediumormedium
supplementedwith 200 mM raffinose for 18 h. Cells were harvested and assayedas above. Errorbars are the SD. The P-value was calculated with an unpairedtwo-
tailed t-test.Resultsare from fourindependentexperiments. (D) Nuclearextracts from mockor raffinosetreated L929cells transfected withthe U6 constructswere
also analyzed by western blot analysis with an antibody to NFAT5, which demonstrates specific knockdown of NFAT5 protein levels by the U6-N5 ex8 vectora s
shown.(E)AvectorexpressingadominantnegativeNFAT5decreaseshypertonicinductionofTNF-Lucactivity.L929cellswereco-transfectedbyDEAE-dextran
with TNF-Luc, pTK-RL, and different amounts of either pcDNA3, N5-DN or both vectors as indicated. Cells were stimulated and extracts were assayed as above.
The P-value was calculated with an unpaired two-tailed t-test. Results are from four independent experiments.
3852 Nucleic Acids Research, 2005, Vol. 33, No. 12absence of NFATp (since L929 cells do not contain NFATp
[Figure 1C and see (1)], activates TNF transcription via
NFAT5.
Notably, NFAT5 has been shown to be involved in T
lymphocyte development and survival (16). Murine lymphoid
tissues are hypertonic, and heterozygous NFAT5 knockout
mice show defective proliferation of lymphocytes under
hypertonic conditions (35). These results indicate that
NFAT5 could play a role in the regulation of TNF during
lymphocyte proliferation, although to date there is no direct
evidence that NFAT5 regulates TNF transcription in T
lymphocytes under isotonic conditions. For example, TNF
production was not affected in N5-DN transgenic primary
Con A blasts activated with PMA and ionomycin (36). This
result is consistent with the critical and non-redundant role of
NFATp in immediate early TNF production in T cells (2).
However, given that rapidly dividing cells become hypotonic
relative to their extracellular environment due to rapid volume
increase (37), it is intriguing to speculate that NFAT5 could
co-regulate both cellular tonicity and TNF production at later
time points while T cells are undergoing rapid clonal expan-
sion during the immune response.
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